DK1458413T3 - Farmaceutiske sammensætninger på b asis af azetidin-derivater - Google Patents

Farmaceutiske sammensætninger på b asis af azetidin-derivater

Info

Publication number: DK1458413T3
Authority: DK; Denmark
Prior art keywords: asis; pharmaceutical compositions; azetidine derivatives; azetidine; derivatives
Prior art date: 2001-12-21

Application number

DK02801165T

Other languages

English (en)

Inventor

Maria-Teresa Peracchia

Valerie Bobineau

Sophie Cote

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-21

Filing date

2002-12-20

Publication date

2009-11-23

2002-12-20 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2009-11-23 Application granted granted Critical

2009-11-23 Publication of DK1458413T3 publication Critical patent/DK1458413T3/da

Links

150000001539 azetidines Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Psychiatry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Obesity (AREA)
Hematology (AREA)
Psychology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK02801165T 2001-12-21 2002-12-20 Farmaceutiske sammensætninger på b asis af azetidin-derivater DK1458413T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0116638A FR2833842B1 (fr)	2001-12-21	2001-12-21	Compositions pharmaceutiques a base de derives d'azetidine
PCT/FR2002/004514 WO2003053431A2 (fr)	2001-12-21	2002-12-20	Compositions pharmaceutiques a base de derives d'azetidine

Publications (1)

Publication Number	Publication Date
DK1458413T3 true DK1458413T3 (da)	2009-11-23

Family

ID=8870824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02801165T DK1458413T3 (da)	2001-12-21	2002-12-20	Farmaceutiske sammensætninger på b asis af azetidin-derivater

Country Status (31)

Country	Link
EP (1)	EP1458413B1 (da)
JP (1)	JP5021887B2 (da)
KR (1)	KR20040068308A (da)
CN (1)	CN100388918C (da)
AP (1)	AP1754A (da)
AR (1)	AR037687A1 (da)
AU (1)	AU2002364866B2 (da)
BR (1)	BR0215048A (da)
CA (1)	CA2470443A1 (da)
CO (1)	CO5590911A2 (da)
DE (1)	DE60233071D1 (da)
DK (1)	DK1458413T3 (da)
EA (1)	EA006510B1 (da)
EC (1)	ECSP045162A (da)
FR (1)	FR2833842B1 (da)
HR (1)	HRP20040575A2 (da)
HU (1)	HUP0402586A3 (da)
IL (1)	IL162563A0 (da)
MA (1)	MA27086A1 (da)
ME (1)	MEP16608A (da)
MX (1)	MXPA04005558A (da)
MY (1)	MY138172A (da)
NO (1)	NO20042781L (da)
NZ (1)	NZ533225A (da)
OA (1)	OA12750A (da)
PL (1)	PL203248B1 (da)
RS (1)	RS55504A (da)
TW (1)	TWI256304B (da)
UA (1)	UA77736C2 (da)
WO (1)	WO2003053431A2 (da)
ZA (1)	ZA200404338B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1498122A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Semi-solid systems containing azetidine derivatives
EP1498123A1 (en) *	2003-07-18	2005-01-19	Aventis Pharma S.A.	Emulsifying systems containing azetidine derivatives
BRPI0507801A (pt)	2004-02-17	2007-07-10	Esteve Labor Dr	compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
FR2879932B1 (fr) *	2004-12-27	2007-03-23	Aventis Pharma Sa	Formulations injectable ou administrable par voie orale de derives d'azetidine
NZ564759A (en)	2005-06-30	2011-08-26	Prosidion Ltd	GPCR agonists
AR064736A1 (es)	2007-01-04	2009-04-22	Prosidion Ltd	Agonistas de gpcr
BRPI0806498A2 (pt)	2007-01-04	2014-04-22	Prosidion Ltd	Agonistas gpcr piperidina
WO2008081208A1 (en)	2007-01-04	2008-07-10	Prosidion Limited	Piperidine gpcr agonists
GB0700122D0 (en)	2007-01-04	2007-02-14	Prosidion Ltd	GPCR agonists
CL2008000018A1 (es)	2007-01-04	2008-08-01	Prosidion Ltd	Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
GB0720389D0 (en)	2007-10-18	2008-11-12	Prosidion Ltd	G-Protein Coupled Receptor Agonists
GB0720390D0 (en)	2007-10-18	2007-11-28	Prosidion Ltd	G-Protein coupled receptor agonists
FR2923719B1 (fr) *	2007-11-15	2009-11-20	Sanofi Aventis	Compositions pharmaceutiques a base de derives d'azetidine
FR2928149B1 (fr)	2008-02-29	2011-01-14	Sanofi Aventis	Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2946650B1 (fr) *	2009-06-16	2011-08-19	Sanofi Aventis	Esters derives d'azetidines, leur preparation et leur application en therapeutique.
UA153183U (uk)	2022-10-27	2023-05-31	Андрій Валерійович Максимов	Стаканчик для приготування напою

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR73668B (da) *	1978-11-21	1984-03-28	Hoffmann La Roche
US5631365A (en) *	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
HRP980026A2 (en) *	1998-01-20	1999-10-31	Pliva Pharm & Chem Works	1-izothiazolydinone derivatives of azetidine-2-ones, processes for the preparation and use thereof
WO2000003753A2 (en) *	1998-07-14	2000-01-27	Em Industries, Inc.	Microdisperse drug delivery systems
FR2783246B1 (fr) *	1998-09-11	2000-11-17	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les medicaments les contenant
FR2805810B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation
FR2805818B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
FR2805817B1 (fr) *	2000-03-03	2002-04-26	Aventis Pharma Sa	Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
FR2814678B1 (fr) *	2000-10-04	2002-12-20	Aventis Pharma Sa	Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite

2001
- 2001-12-21 FR FR0116638A patent/FR2833842B1/fr not_active Expired - Fee Related
2002
- 2002-12-02 AR ARP020104646A patent/AR037687A1/es unknown
- 2002-12-03 TW TW091135077A patent/TWI256304B/zh active
- 2002-12-20 MX MXPA04005558A patent/MXPA04005558A/es active IP Right Grant
- 2002-12-20 EP EP02801165A patent/EP1458413B1/fr not_active Expired - Lifetime
- 2002-12-20 AP APAP/P/2004/003066A patent/AP1754A/en active
- 2002-12-20 JP JP2003554188A patent/JP5021887B2/ja not_active Expired - Fee Related
- 2002-12-20 IL IL16256302A patent/IL162563A0/xx unknown
- 2002-12-20 HU HU0402586A patent/HUP0402586A3/hu unknown
- 2002-12-20 BR BR0215048-4A patent/BR0215048A/pt not_active IP Right Cessation
- 2002-12-20 WO PCT/FR2002/004514 patent/WO2003053431A2/fr not_active Ceased
- 2002-12-20 HR HR20040575A patent/HRP20040575A2/hr not_active Application Discontinuation
- 2002-12-20 NZ NZ533225A patent/NZ533225A/en not_active IP Right Cessation
- 2002-12-20 MY MYPI20024828A patent/MY138172A/en unknown
- 2002-12-20 ME MEP-166/08A patent/MEP16608A/xx unknown
- 2002-12-20 DE DE60233071T patent/DE60233071D1/de not_active Expired - Lifetime
- 2002-12-20 OA OA1200400178A patent/OA12750A/fr unknown
- 2002-12-20 UA UA20040706001A patent/UA77736C2/uk unknown
- 2002-12-20 CA CA002470443A patent/CA2470443A1/fr not_active Abandoned
- 2002-12-20 PL PL372708A patent/PL203248B1/pl not_active IP Right Cessation
- 2002-12-20 RS YUP-555/04A patent/RS55504A/sr unknown
- 2002-12-20 DK DK02801165T patent/DK1458413T3/da active
- 2002-12-20 CN CNB028248406A patent/CN100388918C/zh not_active Expired - Fee Related
- 2002-12-20 KR KR10-2004-7009708A patent/KR20040068308A/ko not_active Ceased
- 2002-12-20 AU AU2002364866A patent/AU2002364866B2/en not_active Ceased
- 2002-12-20 EA EA200400843A patent/EA006510B1/ru not_active IP Right Cessation
2004
- 2004-05-21 MA MA27694A patent/MA27086A1/fr unknown
- 2004-06-02 ZA ZA200404338A patent/ZA200404338B/en unknown
- 2004-06-17 CO CO04056913A patent/CO5590911A2/es not_active Application Discontinuation
- 2004-06-18 EC EC2004005162A patent/ECSP045162A/es unknown
- 2004-07-01 NO NO20042781A patent/NO20042781L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN100388918C (zh)	2008-05-21
CO5590911A2 (es)	2005-12-30
AU2002364866B2 (en)	2006-11-30
EA006510B1 (ru)	2005-12-29
MA27086A1 (fr)	2004-12-20
CN1602206A (zh)	2005-03-30
TW200301108A (en)	2003-07-01
HRP20040575A2 (en)	2004-10-31
TWI256304B (en)	2006-06-11
HK1070840A1 (zh)	2005-06-30
HUP0402586A3 (en)	2011-05-30
WO2003053431A3 (fr)	2003-12-18
JP5021887B2 (ja)	2012-09-12
DE60233071D1 (de)	2009-09-03
OA12750A (fr)	2006-07-03
AU2002364866A1 (en)	2003-07-09
PL203248B1 (pl)	2009-09-30
CA2470443A1 (fr)	2003-07-03
ECSP045162A (es)	2004-08-27
ZA200404338B (en)	2005-06-02
BR0215048A (pt)	2004-11-03
AP2004003066A0 (en)	2004-06-30
NO20042781L (no)	2004-09-20
HUP0402586A2 (hu)	2005-03-29
FR2833842B1 (fr)	2004-02-13
IL162563A0 (en)	2005-11-20
UA77736C2 (en)	2007-01-15
NZ533225A (en)	2007-02-23
JP2005516945A (ja)	2005-06-09
EA200400843A1 (ru)	2004-12-30
EP1458413A2 (fr)	2004-09-22
AP1754A (en)	2007-07-18
EP1458413B1 (fr)	2009-07-22
MEP16608A (en)	2010-06-10
MY138172A (en)	2009-04-30
KR20040068308A (ko)	2004-07-30
PL372708A1 (en)	2005-07-25
FR2833842A1 (fr)	2003-06-27
RS55504A (sr)	2007-06-04
AR037687A1 (es)	2004-12-01
WO2003053431A2 (fr)	2003-07-03
MXPA04005558A (es)	2004-12-06

Publication	Publication Date	Title
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
PL367180A1 (pl)	2005-02-21	Trwała kompozycja farmaceutyczna
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
PT1242087E (pt)	2004-06-30	Composicoes farmaceuticas
EE200300416A (et)	2003-12-15	Ravimvorm
DK1395242T3 (da)	2006-10-30	Flydende farmaceutisk sammensætning
EE05020B1 (et)	2008-06-16	Glburiidi ravimkoostis
PT1467724E (pt)	2006-08-31	Composicao farmaceutica orodispersavel de agomelatina
EE200300589A (et)	2004-02-16	Ravimkoostised
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
PT1239832E (pt)	2004-10-29	Composicoes farmaceuticas
DE60233071D1 (de)	2009-09-03	Pharmazeutische zusammensetzungen auf basis von azetidinderivaten
NO20034556D0 (no)	2003-10-10	Imidazotriazinon-holdige sammensetninger for nasal administrering
DK1475379T3 (da)	2007-09-03	Anvendelse af scopinesterderivater til fremstilling af lægemidler
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NO20020524L (no)	2002-08-02	Stabiliserte organisk-peroksid sammensetninger
DE50208676D1 (de)	2006-12-28	Builder-Zusammensetzung
NO20044164L (no)	2004-09-30	Farmasoytiske sammensetninger
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet